The DABOM Inc. specializes in the development of artificial exosomes using advanced microfluidic technology. Their innovative approach to drug delivery ensures high precision and biocompatibility, significantly minimizing the side effects often associated with traditional lipid nanoparticles. The company’s proprietary Exostation™ platform enhances the loading and release of therapeutic agents, catering to various medical applications.
Contact Information:
Website: https://www.thedabom.com
Email: info@thedabom.com
Phone: +1 (555) 123-4567
Address: 123 Innovation Drive, Suite 456, Biotech City, State, ZIP
| Country | Korea |
|---|---|
| Continent | Asia |
